Tamara Intermesoli

Statistics

Publications

Citations

3.1K

H-Index

Active since

2005

Affiliations

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia(Current)

Ospedale Papa Giovanni XXIII

Azienda Ospedaliero-Universitaria delle Marche

University of Bologna

Sapienza University of Rome

Tamara Intermesoli is an author at Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2005–2022

Publications

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani et al. · Blood · 2009 · 430 citations · Full text

Medicine, Oncology, Chemotherapy +13

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Renato Bassan, Giuseppe Rossi, Enrico Maria Pogliani et al. · Journal of Clinical Oncology · 2010 · 274 citations

Medicine, Oncology, Pharmacotherapy +16

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia

Gianantonio Rosti, Francesca Palandri, Fausto Castagnetti et al. · Blood · 2009 · 211 citations · Full text

Medicine, Oncology, Pharmacology +7

Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

Luca Bologna, Elisa Gotti, Massimiliano Manganini et al. · The Journal of Immunology · 2011 · 198 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.

Nicola Vianelli, Monica Galli, Antonio De Vivo et al. · PubMed · 2005 · 180 citations

Medicine, Hematology, Surgery +7

1–5 of 49